☆ 4.1 Article

Desensitization to Brentuximab Vedotin after anaphylaxis in refractory Hodgkin's lymphoma

JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2022)

Related references

Note: Only part of the references are listed.

Article Oncology

Rapid desensitization to brentuximab vedotin after severe anaphylaxis in the treatment of refractory Hodgkin's lymphoma

Rosalaura V. Villarreal-Gonzalez et al.

Summary: This case report describes a 23-year-old female patient with severe anaphylaxis reaction to brentuximab vedotin, which was successfully controlled with desensitization treatment. Rapid drug desensitization may be a favorable option for patients experiencing severe hypersensitivity reactions.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2021)

Add to Collection

Article Oncology

Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study

Martin Hutchings et al.

Summary: The study compared the efficacy and safety of different treatment regimens for Hodgkin lymphoma Stage IV patients, finding that A + AVD treatment improved PFS significantly for IV patients, with higher rates of adverse events such as peripheral neuropathy and neutropenia compared to the ABVD treatment group. In the high-risk patient subgroup, no increased incidence or severity of adverse events was observed.

HEMATOLOGICAL ONCOLOGY (2021)

Add to Collection

Review Allergy

Diagnoses and Management of Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: Reactions to Taxanes and Monoclonal Antibodies

Rafael Bonamichi-Santos et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)

Add to Collection

Article Allergy

Monoclonal Antibodies Hypersensitivity Prevalence and Management

Rafael Bonamichi Santos et al.

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2017)

Add to Collection

Review Allergy

Current Knowledge and Management of Hypersensitivity Reactions to Monoclonal Antibodies

Matthieu Picard et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2017)

Add to Collection

Article Hematology

Brentuximab vedotin desensitization in a patient with refractory Hodgkin's lymphoma

Anubha Arora et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2015)

Add to Collection

Article Allergy

Anaphylaxis to Chemotherapy and Monoclonal Antibodies

Mariana C. Castells

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2015)

Add to Collection

Article Oncology

Successful rapid desensitization to the antibody–drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma

Marie Fizesan et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2015)

Add to Collection

Review Oncology

Multiple Successful Desensitizations to Brentuximab Vedotin: A Case Report and Literature Review

Michael D. DeVita et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)

Add to Collection

Article Hematology

Successful Desensitization to Brentuximab Vedotin After Anaphylaxis

Amy E. O'Connell et al.

Clinical Lymphoma Myeloma & Leukemia (2013)

Add to Collection

Article Allergy

Clinical features and severity grading of anaphylaxis

SGA Brown

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.